Theravance Biopharma, Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
TBPH on Nasdaq
Location
Ugland House, South Church Street, George Town, Grand Cayman, Cayman Islands

Insiders trading volume in the past year

Theravance Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Weiss Asset Management LP 10%+ Owner $76.7 M Sep 19, 2022
Eli Samaha 10%+ Owner $74.5 M +$13.1 M +21.4% May 1, 2024
Rick E. Winningham CHIEF EXECUTIVE OFFICER, Director $17.6 M May 20, 2024
Frank Pasqualone Svp, Chief Business Officer $4.42 M Nov 19, 2021
Andrew A. Hindman Svp, Chief Financial Officer $3.96 M Nov 18, 2022
Kenneth R. Pitzer Svp, Prod Strat & Comm Plng $3.91 M Feb 18, 2022
Philip D. Worboys Svp, Research & Transl Science $3.4 M Nov 19, 2021
Brett A. Grimaud Svp, Gen Counsel And Secretary $3.2 M May 20, 2024
Rhonda Farnum Svp, Comm & Medical Affairs $3.09 M -$42.2 K -1.35% May 20, 2024
Aziz Sawaf Svp & Chief Financial Officer $3 M May 20, 2024
Bradford J. Shafer EVP, Gen. Counsel, Secretary $2.86 M Aug 20, 2021
Richard A. Graham Svp, Research & Development $2.81 M -$118 K -4.04% Feb 20, 2024
Vijay Sabesan Svp, Technical Operations $2.42 M Nov 19, 2021
Aine Miller Svp, Dev & Head Of Ire Office $1.51 M May 20, 2024
Burton G. Malkiel Director $1.19 M May 2, 2023
Ann Brady President, Tbil $1.14 M Feb 18, 2022
William D. Young Director $803 K Apr 26, 2022
Eran Broshy Director $696 K May 8, 2024
Dean J. Mitchell Director $696 K May 8, 2024
Laurie Smaldone Director $556 K May 8, 2024
Donal O'Connor Director $549 K May 8, 2024
Deepika Pakianathan Director $410 K May 8, 2024
Susannah Gray Director $272 K May 8, 2024
Jeremy T. Grant Director $193 K May 8, 2024
James Connor Kelly Director Apr 11, 2023
GSK plc Former 10% Owner Sep 16, 2022

Recent Insider Transactions by Companies or Individuals for Theravance Biopharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership